Diabetes | CHOP Research Institute


Published on
Jul 29, 2022
Dr. Levine’s great pastimes outside of his endocrinology lab are crossword puzzles and flying radio-controlled airplanes with his grandsons.
Published on
Apr 28, 2022
Our Featured Trainee for April, Anna Ada Dattoli, PhD, discusses Celebrate Diversity Month and her research on diabetes.

Dr. Hatch-Stein's research interests include diabetes, thyroid disorders, and disorders of growth and puberty. Recent clinical research projects include "Bone Health and Cardiovascular Risk in Turner Syndrome" and "Patterns of Height Velocity in Down Syndrome."

hatchsteinj [at] chop.edu

This is a study that investigates whether an IV medication (teplizumab) will slow or halt the progression of type 1 diabetes in children and adolescents (ages 8 - 17 years).

We are currently enrolling adolescents ages 15-21 of South Asian ancestry, African American ancestry, and European American or "White" ancestry.

You are invited to take part in a voluntary research trial because you have type 2 diabetes and are between the ages of 10 and 17 years.

The Shah Lab investigates obesity and its related complications. Current work includes clinical and translational studies exploring the pathophysiology and modulation of obesity-related adipose tissue and systemic inflammation using human cell lines and clinical trials.

Dr. Pinney’s research focuses on determining the molecular mechanisms that link an adverse intrauterine milieu to the development of diabetes and obesity later in life.

The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes.

The research focus in the Long Lab centers on understanding how the mammalian skeleton is formed and maintained in a functional state throughout life.